Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant JCPyV/JCV Capsid protein VP1 Protein, N-His & C-His

Catalog #:   YVV33002 Specific References (42) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q99FM1
Protein length: Met1-Leu354
Overview

Catalog No.

YVV33002

Expression system

E. coli

Species

JC polyomavirus (JCPyV) (JCV)

Protein length

Met1-Leu354

Predicted molecular weight

42.61 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q99FM1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Capsid protein VP1, VP1

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant JC polyomavirus (JCPyV) (JCV) Capsid protein VP1 protein
References

Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1., PMID:38996969

IgG Seroreactivites to Viral Capsid Protein VP1 of JC and BK Polyomaviruses in Children at Early Ages with Special Reference to Parental Cofactors., PMID:37892308

Designing a Multi-Epitope Subunit Vaccine against VP1 Major Coat Protein of JC Polyomavirus., PMID:37514998

Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years., PMID:36650213

T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus., PMID:36341713

The oncogenic roles of JC polyomavirus in cancer., PMID:36212474

The Inhibition of DNA Viruses by the Amphibian Antimicrobial Peptide Temporin G: A Virological Study Addressing HSV-1 and JPCyV., PMID:35806198

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment., PMID:34578264

Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus., PMID:34113338

JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?, PMID:33053912

Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus., PMID:33008586

Antibody escape by polyomavirus capsid mutation facilitates neurovirulence., PMID:32940605

Investigation of simian virus 40 (SV40) and human JC, BK, MC, KI, and WU polyomaviruses in glioma., PMID:32124265

Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?, PMID:32087593

Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients., PMID:32012272

Molecular epidemiology of JC polyomavirus in HIV-infected patients and healthy individuals from Iran., PMID:31364012

Establishment of COS-JC cells persistently producing archetype JC polyomavirus., PMID:29932215

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution., PMID:29746834

ERK Is a Critical Regulator of JC Polyomavirus Infection., PMID:29321332

Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors., PMID:29243131

Archetype JC Polyomavirus (JCPyV) Prevails in a Rare Case of JCPyV Nephropathy and in Stable Renal Transplant Recipients With JCPyV Viruria., PMID:28968776

Multiplex detection in tonsillar tissue of all known human polyomaviruses., PMID:28595595

Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy., PMID:28453853

Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera., PMID:28321224

Tracing Males From Different Continents by Genotyping JC Polyomavirus in DNA From Semen Samples., PMID:27859215

Polyomaviruses., PMID:27726799

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab., PMID:27164128

Recombinant VLP-Z of JC Polyomavirus: A Novel Vector for Targeting Gene Delivery., PMID:26909539

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy., PMID:26400911

Characterization of Rabbit Antibodies Against the Immunogenic JC Polyomavirus Peptide JCPyV_VP2_167-15mer., PMID:26075335

Characterization of self-assembled virus-like particles of Merkel cell polyomavirus., PMID:25671590

Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins., PMID:25609820

Small-molecule inhibitors of JC polyomavirus infection., PMID:25522925

Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection., PMID:25273879

Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells., PMID:25155602

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy., PMID:24909571

Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding., PMID:23760462

Serological cross-reactivity between human polyomaviruses., PMID:23650080

JC polyomavirus reactivation is not associated with herpes zoster., PMID:16808330

Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy., PMID:15964545

New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy., PMID:15958683

Detection of JC polyomavirus DNA sequences and cellular localization of T-antigen and agnoprotein in oligodendrogliomas., PMID:12429619

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant JCPyV/JCV Capsid protein VP1 Protein, N-His & C-His [YVV33002]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only